Pascal Touchon Atara Biotherapeutics, Inc. (ATRA) insider trading activity

ATRA Quotes by TradingView

Pascal Touchon is President and CEO of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 1.83 Million shares of ATRA, which is worth approximately $15.5 Million. The most recent transaction as insider was on May 16, 2024, when has been sold 81,506 shares (Common Stock) at a price of $0.62 per share, resulting in proceeds of $50,533. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.83M
4.27% 3M change
158.84% 12M change
Total Value Held $15.5 Million

Pascal Touchon Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2024
SELL
Open market or private sale
$50,533 $0.62 p/Share
81,506 Reduced 4.27%
1,829,146 Common Stock
Mar 04 2024
SELL
Open market or private sale
$17,887 $0.72 p/Share
24,844 Reduced 1.28%
1,910,652 Common Stock
Jan 08 2024
BUY
Grant, award, or other acquisition
-
1,280,000 Added 39.81%
1,935,496 Common Stock
Nov 16 2023
SELL
Open market or private sale
$7,959 $0.39 p/Share
20,409 Reduced 3.02%
655,496 Common Stock
Aug 16 2023
SELL
Open market or private sale
$50,763 $1.65 p/Share
30,766 Reduced 4.35%
675,905 Common Stock
Jun 27 2023
SELL
Open market or private sale
$23,723 $1.66 p/Share
14,291 Reduced 1.98%
706,671 Common Stock
May 16 2023
SELL
Open market or private sale
$60,722 $2.04 p/Share
29,766 Reduced 3.96%
720,962 Common Stock
Mar 02 2023
SELL
Open market or private sale
$56,914 $3.63 p/Share
15,679 Reduced 2.05%
750,728 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
324,711 Added 29.76%
766,407 Common Stock
Nov 16 2022
SELL
Open market or private sale
$70,003 $4.49 p/Share
15,591 Reduced 3.41%
441,696 Common Stock
Aug 16 2022
SELL
Open market or private sale
$74,622 $5.04 p/Share
14,806 Reduced 3.14%
457,287 Common Stock
Jun 27 2022
SELL
Open market or private sale
$102,384 $7.2 p/Share
14,220 Reduced 2.92%
472,093 Common Stock
May 17 2022
SELL
Open market or private sale
$74,017 $5.32 p/Share
13,913 Reduced 2.78%
486,313 Common Stock
Mar 01 2022
SELL
Open market or private sale
$87,044 $9.86 p/Share
8,828 Reduced 1.73%
500,226 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
180,565 Added 26.18%
509,054 Common Stock
Nov 16 2021
SELL
Open market or private sale
$143,842 $17.12 p/Share
8,402 Reduced 2.49%
328,489 Common Stock
Aug 17 2021
SELL
Open market or private sale
$103,034 $12.53 p/Share
8,223 Reduced 2.38%
336,891 Common Stock
Jun 25 2021
SELL
Open market or private sale
$231,646 $16.32 p/Share
14,194 Reduced 3.95%
345,114 Common Stock
May 18 2021
SELL
Open market or private sale
$120,954 $14.55 p/Share
8,313 Reduced 2.26%
359,308 Common Stock
Mar 02 2021
SELL
Open market or private sale
$81,808 $16.74 p/Share
4,887 Reduced 1.31%
367,621 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
117,187 Added 23.93%
372,508 Common Stock
Nov 17 2020
SELL
Open market or private sale
$93,235 $19.77 p/Share
4,716 Reduced 1.81%
255,321 Common Stock
PT

Pascal Touchon

President and CEO
South San Francisco, CA

Track Institutional and Insider Activities on ATRA

Follow Atara Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

News

Receive news related to Atara Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATRA